JCR Pharmaceuticals Co Ltd

JCR Pharmaceuticals Co Ltd

Health CarePharmaceuticals & Biotechnology
  • Price (JPY)2,952.00
  • Today's Change25.00 / 0.85%
  • Shares traded288.40k
  • 1 Year change-1.35%
  • Beta1.0063
Data delayed at least 20 minutes, as of Sep 24 2021 07:00 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.

  • Revenue in JPY (TTM)34.72bn
  • Net income in JPY7.66bn
  • Incorporated1975
  • Employees732.00
  • Location
    JCR Pharmaceuticals Co Ltd3-19, Kasuga-choASHIYA-SHI 659-0021JapanJPN
  • Phone+81 797328591
  • Websitehttp://www.jcrpharm.co.jp
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
KAKEN PHARMACEUTICAL CO., LTD.75.36bn12.95bn220.05bn1.22k14.221.3414.372.92336.77336.771,960.633,561.820.46852.243.7362,026,340.008.0512.229.2714.8454.1356.3317.1819.994.44--0.027632.46-15.97-7.33-30.80-8.71-6.601.98
Sawai Group Holdings Co Ltd193.76bn13.18bn224.65bn3.00k17.071.017.561.16300.53300.534,421.525,059.430.49941.533.1764,523,
Tsumura & Co130.89bn16.68bn287.08bn3.83k17.161.2811.462.19217.97217.971,710.762,922.860.40930.72522.6634,173,890.
Hisamitsu Pharmaceutical Co Inc117.39bn11.50bn361.95bn2.77k30.231.3622.803.08140.60140.601,435.283,118.640.39332.573.3942,378,700.003.955.944.406.7760.1162.1710.0412.636.73--0.005439.53-18.78-6.69-50.52-12.25-8.030.8601
JCR Pharmaceuticals Co Ltd34.72bn7.66bn379.59bn732.0047.469.3039.4510.9361.6761.67279.63314.850.52340.67133.9847,427,600.0011.548.2918.5710.6875.7969.8522.0515.611.16--0.316426.8821.4011.52157.3630.9639.7118.13
TAKARA BIO INC.54.42bn15.17bn386.53bn1.54k25.484.8120.447.10125.96125.96451.94668.000.62821.555.5335,360,620.0017.565.7720.256.3774.0761.3327.9611.662.71--0.0022.9533.339.16149.9948.2330.0954.80
Alfresa Holdings Corporation2.60tn22.03bn398.12bn12.05k16.280.737811.680.1533104.09104.0912,267.732,296.011.9216.154.29215,586,900.001.632.644.237.256.787.330.84791.321.07--0.001227.87-3.530.2069-39.16-6.875.049.94
ROHTO PHARMACEUTICAL CO., LTD.184.96bn19.54bn410.95bn6.60k20.382.4715.622.22170.78170.781,616.791,406.330.84282.384.6128,041,390.008.926.1312.008.7558.8659.4710.586.961.82--0.058722.70-3.741.658.6512.9716.856.96
Peptidream Inc11.45bn4.33bn485.59bn128.00112.1521.8998.7642.4133.3033.3088.90170.590.52013.7813.1889,445,060.0019.66--21.52--80.85--37.81--6.70--0.00--------------
Medipal Holdings Corp3.24tn26.47bn527.44bn12.97k18.250.856810.320.1627118.18118.1814,532.312,517.511.9320.264.57249,929,700.002.182.635.967.426.637.131.131.331.07--0.044925.33-1.291.18-36.98-4.91-16.418.45
Data as of Sep 24 2021. Currency figures normalised to JCR Pharmaceuticals Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

7.38%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 31 Aug 20212.34m1.80%
The Vanguard Group, Inc.as of 03 Sep 20211.32m1.02%
Norges Bank Investment Managementas of 31 Dec 2020920.40k0.71%
Nikko Asset Management Co., Ltd.as of 02 Sep 2021866.60k0.67%
Daiwa Asset Management Co. Ltd.as of 31 Aug 2021857.80k0.66%
Shiozumi Asset Management Co. Ltd.as of 31 Jul 2021790.00k0.61%
BlackRock Fund Advisorsas of 02 Sep 2021741.40k0.57%
Tokio Marine Asset Management Co., Ltd.as of 21 Jun 2021714.60k0.55%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 02 Sep 2021536.40k0.41%
Asset Management One Co., Ltd.as of 31 Aug 2021490.09k0.38%
More ▼
Data from 31 Dec 2020 - 31 Jul 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.